SAB Biotherapeutics (SABS)
(Delayed Data from NSDQ)
$2.84 USD
-0.06 (-2.07%)
Updated Sep 6, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -1.07 |
EPS Last Quarter | -0.79 |
Last EPS Surprise | 30.09% |
ABR | 1.00 |
Earnings ESP
|
0.77% |
---|---|
Current Year | -3.59 |
Next Year | -2.97 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.50M | 0.50M | 1.45M | 2.00M |
# of Estimates | 1 | 1 | 4 | 1 |
High Estimate | 0.50M | 0.50M | 2.20M | 2.00M |
Low Estimate | 0.50M | 0.50M | 1.20M | 2.00M |
Year ago Sales | 1.27M | NA | 2.24M | 1.45M |
Year over Year Growth Est. | -60.63% | NA | -35.06% | 37.55% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.07 | -1.13 | -3.59 | -2.97 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -1.06 | -1.14 | -3.68 | -3.60 |
High Estimate | -1.06 | -1.06 | -3.48 | -0.95 |
Low Estimate | -1.09 | -1.21 | -3.68 | -5.01 |
Year ago EPS | -1.00 | NA | -7.64 | -3.59 |
Year over Year Growth Est. | -7.00% | NA | 53.01% | 17.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 3 | 2 |
Up Last 60 Days | 1 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.07 | -1.13 | -3.59 | -2.97 |
7 Days Ago | -1.07 | -1.13 | -3.59 | -2.97 |
30 Days Ago | -1.17 | -1.24 | -4.08 | -3.26 |
60 Days Ago | -1.17 | -1.24 | -4.08 | -3.26 |
90 Days Ago | -1.17 | -1.24 | -4.08 | -3.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.07 | -1.13 | -3.59 | -2.97 |
Zacks Consensus Estimate | -1.07 | -1.13 | -3.59 | -2.97 |
Earnings ESP | 0.77% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.79 | -0.54 | NA | -1.00 | NA |
Estimate | -1.13 | -0.98 | NA | -1.00 | NA |
Difference | 0.34 | 0.44 | NA | 0.00 | 0.26 |
Surprise | 30.09% | 44.90% | NA | 0.00% | 25.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more